SOS Small Cell Lung Cancer AECC
@sosclc-aecc.bsky.social
SOSCLC-AECC is a scientific network of biomedical researchers and clinicians with a focus on Small Cell Lung Cancer (SCLC) and neuroendocrine lung tumors. Coordinated by Luis Paz-Ares (H12O) and @mmalumbres.bsky.social @vhio.bsky.social, and funded by AECC
El cáncer de pulmón aumenta en mujeres y arrasa en España. En la red SOSCLC.ORG trabajaremos en las bases científicas y las implicaciones sociales de este problema! www.eldiario.es/sociedad/can...
El cáncer de pulmón en mujeres ya provoca casi tantas muertes como el de mama en España
Este año se diagnosticarán 296.103 nuevos casos de cáncer en España, un 3,29 % más que en 2024, según la estimación anual que hace la Sociedad Española de Oncología Médica (SEOM)
eldiario.es
2024 approvals: Summary of 14 new drugs/indications in #LungCancer by FDA 1. #Tepotinib 2. #Osimertinib x2 3. #Alectinib 4. #Tarlatamab 5. #Zenocutuzumab 6. #Durvalumab x2 7. #Amivantamab x2 8. #Nivolumab (now SubQ) 9. #Ensartinib #lcsm #OncSky #MedSky #Cancer
5 papers about Lung Cancer suggested by Stephen Liu @stephenvliu.bsky.social oncodaily.com/science/step... #Cancer #GeorgetownUniversity #LungCancer #Nivolumab #NSCLC #OncoDaily #Oncology #Osimertinib #Health #PATHER2study #SCLC #TimeToxicity #Medicine
5 papers about Lung Cancer suggested by Stephen Liu - OncoDaily
5 papers about Lung Cancer suggested by Stephen Liu / Alessandro Brunelli, Anne Gulbech Ording, cancer, Dániel Sztankovics, Georgetown University, Jii Bum
oncodaily.com
Our lab malumbreslab.org @vhio.bsky.social will join CIBERONC in 2025. Thanks for counting on us!! www.ciberonc.es/en
@casanova-acebes.bsky.social, a member of the @sosclc-aecc.bsky.social, receives an ERC grant to improve cancer therapies! elpais.com/salud-y-bien...
Por qué es importante ajustar las terapias oncológicas a los ritmos circadianos de los pacientes
Las últimas investigaciones señalan el gran potencial terapéutico de la cronoterapia
elpais.com
Follow our #SLCL starter pack for more news on #lung #cancer #oncosky #oncsky 🧪
SOS Small Cell Lung Cancer AECC@sosclc-aecc.bsky.social · 2y agoOur @sosclc-aecc.bsky.social researcher @crismayorruiz.bsky.social reports a new therapeutic strategy against #lung #cancer. A perfect example of the ideas to be developed within the #SCLC network! #oncosky #oncsky 🧪
Our @sosclc-aecc.bsky.social researcher @crismayorruiz.bsky.social reports a new therapeutic strategy against #lung #cancer. A perfect example of the ideas to be developed within the #SCLC network! #oncosky #oncsky 🧪
@crismayorruiz.bsky.social · 2y agoHi BlueSky world! We are thrilled to share our new preprint around oncoprotein degradation in vivo —a fantastic collaboration with our friends in Salamanca #lab_santamaria #ciccancer! 😃 @irbbarcelona.bsky.social #TPD #KRAS 👇 www.biorxiv.org/content/10.1...
Real-world analysis of 1L carboplatin, etoposide, atezolizumab for extensive stage #SCLC with ≥3y f/u published in Lung Cancer. In 207 pts, the 3y OS rate was 21%. Need to build on this backbone, but long-term survival is possible for some. #LCSM #OncSky www.lungcancerjournal.info/article/S016...
DEFINE_ME
lungcancerjournal.info
The OncoAlert 🚨Newsletter NOW OUT Covering September November 28-Dec 5, 2024 REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0 ✅FDA Approves Duvalumab in #SCLC 🫁🇺🇸 ✅FDA ACCELERATED APPROVAL TO ZENOCUTUZUMAB-ZBCO IN #NSCLC 🫁 ✅Lung adenocarcinomas with mucinous & more
A starter pack with researchers, clinicians, associations and patients wirh interest in Small Cell Lung Cancer #SCLC and related lung neuroendocrine tumors. Please contact us if interested in being included or have any suggestion go.bsky.app/HmjASG1
Living with lung cancer isn’t just about battling a disease; it’s about navigating an entirely different reality. These quotes are a glimpse into the struggles, fears, and uncertainties faced by those living with young lung cancer every day. 💔 #LivingWithLungCancer #CancerAdvocacy #lcsm
@sosclc-aecc.bsky.social researcher Dolores Isla talks in El Mundo about current challenges in lung cancer..
Soyxavigranda@soyxavigranda.bsky.social · 2y agoPor si fuera de interés, escribo en El Mundo sobre avances y retos en cáncer de pulmón, en una conversación con la doctora Dolores Isla www.elmundo.es/uestudio/202...
A Starter Pack with Small Cell Lung Cancer #SCLC accounts! #oncsky #oncosky 🧪
SOS Small Cell Lung Cancer AECC@sosclc-aecc.bsky.social · 2y agoA starter pack with researchers, clinicians, associations and patients wirh interest in Small Cell Lung Cancer #SCLC and related lung neuroendocrine tumors. Please contact us if interested in being included or have any suggestion go.bsky.app/HmjASG1
A starter pack with researchers, clinicians, associations and patients wirh interest in Small Cell Lung Cancer #SCLC and related lung neuroendocrine tumors. Please contact us if interested in being included or have any suggestion go.bsky.app/HmjASG1
Why #lungcancer (the #1 cancer killer) needs more funding and research: Only 2 of the 7 LC patient advocates in this 2018 photo are still alive (including me). While newer treatments like targeted therapy and immune checkpoint inhibitors are effective for some, they don't work for all. #LCSM
New therapies in SCLC: FDA approves durvalumab for limited-stage small cell lung cancer www.fda.gov/drugs/resour...
FDA approves durvalumab for limited-stage small cell lung cancer
On December 4, 2024, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) for limited-stage small cell lung cancer (LS-SCLC).
fda.gov
An insightful review on genetics and resistance to immunotherapies in cancer by @sosclc-aecc.bsky.social researcher @franmj88.bsky.social @vhio.bsky.social www.cell.com/trends/cance...
Genetic immune escape in cancer: timing and implications for treatment
Genetic immune escape (GIE) alterations pose a significant challenge in cancer by enabling tumors to evade immune detection. These alterations, which can vary significantly across cancer types, may often arise early in clonal evolution and contribute to malignant transformation. As tumors evolve, GIE alterations are positively selected, allowing immune-resistant clones to proliferate. In addition to genetic changes, the tumor microenvironment (TME) and non-genetic factors such as inflammation, smoking, and environmental exposures play crucial roles in promoting immune evasion. Understanding the timing and mechanisms of GIE, alongside microenvironmental influences, is crucial for improving early detection and developing more effective therapeutic interventions. This review highlights the implications of GIE in cancer development and immunotherapy resistance, and emphasizes the need for integrative approaches.
cell.com
Fran Martínez-Jiménez@franmj88.bsky.social · 2y agoExcited to share our perspective on genetic immune escape alterations and their impact on tumor evolution, metastasis, immunotherapy, and interactions with tumor-extrinsic factors. It was a pleasure collaborating with Diego on this -hope you enjoy the read!☺️ www.sciencedirect.com/science/arti...
2 new studies in Nature reveal how isoprene—a gas from plants—forms particles in the upper atmosphere, improving climate models. Better understanding of air quality & particle behaviour could aid future research into impacts on lung health inclu. #lungcancer #LCSM www.nature.com/nature/volum...
